Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2003-05-28
2008-12-02
Kam, Chih-Min (Department: 1656)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S236100, C424S009100, C514S012200, C514S002600, C530S350000, C435S252700
Reexamination Certificate
active
07459164
ABSTRACT:
This invention relates to a composition of botulinum based pharmaceuticals used for therapeutic and cosmetic treatment. This invention offers an improvement on the prior art by eliminating the potential of blood-borne contamination with botulinum based pharmaceuticals. Recombinant serum albumin is taught for use in the place of human serum albumin as a stabilizing or enhancing agent.
REFERENCES:
patent: 4861627 (1989-08-01), Mathiowitz et al.
patent: 5069936 (1991-12-01), Yen
patent: 5512547 (1996-04-01), Johnson et al.
patent: 5576468 (1996-11-01), Lubowitz
patent: 5696077 (1997-12-01), Johnson et al.
patent: 5756468 (1998-05-01), Johnson et al.
patent: 5846929 (1998-12-01), Johnson et al.
patent: 6100306 (2000-08-01), Li et al.
patent: 6210707 (2001-04-01), Papahadjopoulos et al.
patent: 6312706 (2001-11-01), Lai et al.
patent: 6620617 (2003-09-01), Mathiowitz et al.
patent: 2002/0064536 (2002-05-01), Hunt
patent: 2003/0138437 (2003-07-01), Hunt
patent: 2004/0126396 (2004-07-01), Aoki et al.
patent: 2004/0151741 (2004-08-01), Borodic
patent: WO 94/00481 (1994-01-01), None
patent: WO 97/35604 (1997-10-01), None
patent: WO 01/58472 (2001-08-01), None
Borodic, “Botulinum A Toxin for (expressionistic) ptosis overcorrection after frontalis sling,” Ophtalmic Plastic & Recostructive Surg. 8(2): 137-142, (1992).
Borodic et al. Botulinum A Toxin for the treatment of spasmodic torticollis, Dysphagia and Regional Toxin Spread. Head & Neck, 12: 392-398 (1990).
Nussgens et al. “Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm,” Graefes Arch Clin Exp Ophthalmol 235(4): 197-199 (1997).
Bigalke et al. Botulinum A Toxin: DYSPORT improvement of biological availability,: Exp. Neurol. 168(1): 162-170 (2001).
Lew et al. “Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia,” Neurology 49(3): 701-707 (1997).
Borodic et al “Botulinum Toxin: Clinical and Scientific Aspects.” Ophthalmology Clinics of North America 4: 491-503 (1991).
Borodic et al “Botulinum: a toxin for spasmodic torticollis, multiple vs single injection points per muscle,” Head and Neck 14:33-37 (1992).
Ranoux et al “Respective potencies of BOTOX and DYSPORT: a double blind, randomized, crossover study in cervical dystonia,” J. Neuro. Neurosurg. Psychiatry 72: 459-462 (2002).
Borodic et al., “Botulinum toxin therapy. immunologic resistance, and problems with available materials,” Views and Reviews, Neurology 1996; 46:26-29.
Borodic et al., “Botulinum B Toxin as an Alternative to Botulinum A Toxin, A Histologic Study,” Opthalmic Plastic and Reconstructive Surgery 9(3): 182-190 (1993).
Journal of Clin Anesth. 11(7): 615-6, (Nov. 1999).
Borodic et al. “Botulinum A Toxin for Treatment of Aberrant Facial Nerve Regeneration,” Plastic and Reconstructive Surger, (91)6: 1042-4045, 1993.
Borodic, Gary “Botulinum toxin: issues and application,” Current Opinion in Otolaryngology & Head and Neck Surgery, 1999, 7:219-255.
Acquadro, Martin A. et al. “Treatment of Myofascial Pain with Botulinum A Toxin,” Anesthesiology, Volo. 80, No. 3, Mar. 1994, pp. 705-706.
Schantz, Edward J. et al. “Standardized Assay for Clostridium botulinum Toxins,” Journal of the AOAC, vol. 61, No. 1, 1978, pp. 96-99.
Botulinum Toxin Research Associates, Inc.
Kam Chih-Min
Milbank Tweed Hadley & McCloy LLP
LandOfFree
Composition for therapeutic and cosmetic botulinum toxin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for therapeutic and cosmetic botulinum toxin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for therapeutic and cosmetic botulinum toxin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4046792